Jeffrey Sevigny

Business address
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY, 10016
Top holdings (ownership)
ABOS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jeffrey Sevigny has filed 8 SEC EDGAR filings since 19 Jun 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 03 Apr 2025 01 Apr 2025 001-42121
3 Open Document Open Filing 3 05 Mar 2025 03 Mar 2025 001-42121
4 Open Document Open Filing FORM 4 SUBMISSION 17 Jun 2022 15 Jun 2022 001-40551
4 Open Document Open Filing FORM 4 SUBMISSION 02 Jul 2021 30 Jun 2021 001-40551
3 Open Document Open Filing FORM 3 SUBMISSION 30 Jun 2021 30 Jun 2021 001-40551
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jan 2021 22 Jan 2021 001-38939
4 Open Document Open Filing FORM 4 SUBMISSION 11 Mar 2020 19 Feb 2020 001-38939
3 Open Document Open Filing FORM 3 SUBMISSION 19 Jun 2019 19 Jun 2019 001-38939